Gian Marco Guerin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gian Marco Guerin has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Daniele Tognetto
Department of Medicine, Surgery and Health Sciences, University of Trieste, 34129 Trieste, Italy
2 shared publications - Pier Luigi Guerin
Eye Clinic, Department of Medical, Surgical Sciences and Health, University of Trieste, 34129 Trieste, Italy
2 shared publications - Gabriella Cirigliano
Eye Clinic, Department of Medical, Surgical Sciences and Health, University of Trieste, 34129 Trieste, Italy
1 shared publication - Marco Rocco Pastore
Eye Clinic, Department of Medical, Surgical Sciences and Health, University of Trieste, Trieste, Italy
1 shared publication - Stefano Gouigoux
Eye Clinic, Department of Medical, Surgical Sciences and Health, University of Trieste, 34127 Trieste, Italy
1 shared publication
Latest Publications
- Open Access
- 19 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5848
Reducing Postoperative Needling in XEN63® Surgery with Adjunctive Cross-Linked Hyaluronic Acid Implant (Healaflow®): Early Evidence from Real-World Practice
Background: Open-angle glaucoma (OAG) is a leading cause of irreversible blindness. While trabeculectomy remains the surgical gold standard, bleb-forming minimally invasive procedures such as the XEN63 gel stent offer a safer alternative. However, early postoperative management remains critical, as needling is frequently required to preserve bleb function. Healaflow® (HF), a cross-linked hyaluronic acid gel, has been proposed as an adjunct in glaucoma surgery to maintain the subconjunctival space and modulate fibrosis. This study aimed to evaluate the outcomes of XEN63 implantation with or without HF in terms of IOP reduction, glaucoma medication use, surgical success, and postoperative intervention rates. Methods: This retrospective, comparative study included 20 pseudophakic eyes with medically uncontrolled OAG undergoing XEN63 implantation with mitomycin-C (MMC), either with (n = 10) or without (n = 10) adjunctive HF. Follow-up included IOP measurements, medication use, and the need for postoperative procedures up to 3 months. Results: At 3 months, both groups showed significant IOP reduction from baseline (−31.8% in XENhf vs. −38.8% in XENa, p > 0.05) with minimal medication use. Complete success was achieved in 90% of XENhf eyes and 80% of XENa eyes. Although the proportion of eyes requiring needling did not differ significantly, the total number of procedures was lower in the HF group (2 vs. 8; p = 0.004). Conclusions: Adjunctive HF use in XEN63 surgery may reduce the number of postoperative procedures while maintaining equivalent efficacy and safety, potentially easing the early management burden for both patients and clinicians.
- 19 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5848
Open AccessReducing Postoperative Needling in XEN63® Surgery with Adjunctive Cross-Linked Hyaluronic Acid Implant (Healaflow®): Early Evidence from Real-World Practice
Background: Open-angle glaucoma (OAG) is a leading cause of irreversible blindness. While trabeculectomy remains the surgical gold standard, bleb-forming minimally invasive procedures such as the XEN63 gel stent offer a safer alternative. However, early postoperative management remains critical, as needling is frequently required to preserve bleb function. Healaflow® (HF), a cross-linked hyaluronic acid gel, has been proposed as an adjunct in glaucoma surgery to maintain the subconjunctival space and modulate fibrosis. This study aimed to evaluate the outcomes of XEN63 implantation with or without HF in terms of IOP reduction, glaucoma medication use, surgical success, and postoperative intervention rates. Methods: This retrospective, comparative study included 20 pseudophakic eyes with medically uncontrolled OAG undergoing XEN63 implantation with mitomycin-C (MMC), either with (n = 10) or without (n = 10) adjunctive HF. Follow-up included IOP measurements, medication use, and the need for postoperative procedures up to 3 months. Results: At 3 months, both groups showed significant IOP reduction from baseline (−31.8% in XENhf vs. −38.8% in XENa, p > 0.05) with minimal medication use. Complete success was achieved in 90% of XENhf eyes and 80% of XENa eyes. Although the proportion of eyes requiring needling did not differ significantly, the total number of procedures was lower in the HF group (2 vs. 8; p = 0.004). Conclusions: Adjunctive HF use in XEN63 surgery may reduce the number of postoperative procedures while maintaining equivalent efficacy and safety, potentially easing the early management burden for both patients and clinicians.
- Open Access
- 1 June 2024
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 50 (6) , 605-610
Long-term functional outcome between Yamane technique and retropupillary iris-claw technique in a large study cohort
Purpose: To evaluate which secondary intraocular lens (IOL) implantation technique was more successful in achieving the best postoperative results and refractive outcomes between retropupillary iris-claw IOL (ICIOL) and flanged intrascleral IOL (FIIOL) fixation with the Yamane technique. Setting: Eye Clinic of the University of Trieste, Trieste, Italy. Design: Retrospective observational study. Methods: 116 eyes of 110 patients who underwent ICIOL or FIIOL were analyzed. Patients with follow-up shorter than 6 months or with incomplete clinical data were excluded. Collected data included demographics, ocular comorbidity, indication of surgery, intraocular pressure, early (≤1 month) and late (>1 month) postoperative complications, corrected distance visual acuity (CDVA), and manifest refraction at the last follow-up visit. Results: 50% (n = 58) of eyes underwent FIIOL and 50% (n = 58) ICIOL implantation for aphakia (n = 44, 38%) and IOL dislocation (n = 72, 62%). No statistically significant differences in demographics, comorbidity, follow-up duration, postoperative complications, and surgical indications were found. The refractive prediction error (RPE) was 0.69 ± 0.94 diopter (D) in the FIIOL group and 0.21 ± 0.75 D in the ICIOL group (P = .03), indicating residual hyperopia after both techniques. RPE, mean absolute error, and median absolute error were higher in the FIIOL group (P = .003). ICIOL implantation was more successful in obtaining a RPE between −0.50 D and +0.50 D (52% of ICIOL, n = 30, and 31% of FIIOL, n = 18). Conclusions: Both techniques were effective in increasing preoperative CDVA with no statistical difference between them. Although complication rates did not significantly differ, the FIIOL group exhibited less predictable refractive outcomes. Adjusting the dioptric power of the 3-piece IOL, as performed in ciliary sulcus implantation, to prevent myopic shift, is not recommended.
- 1 June 2024
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 50 (6) , 605-610
Open AccessLong-term functional outcome between Yamane technique and retropupillary iris-claw technique in a large study cohort
Purpose: To evaluate which secondary intraocular lens (IOL) implantation technique was more successful in achieving the best postoperative results and refractive outcomes between retropupillary iris-claw IOL (ICIOL) and flanged intrascleral IOL (FIIOL) fixation with the Yamane technique. Setting: Eye Clinic of the University of Trieste, Trieste, Italy. Design: Retrospective observational study. Methods: 116 eyes of 110 patients who underwent ICIOL or FIIOL were analyzed. Patients with follow-up shorter than 6 months or with incomplete clinical data were excluded. Collected data included demographics, ocular comorbidity, indication of surgery, intraocular pressure, early (≤1 month) and late (>1 month) postoperative complications, corrected distance visual acuity (CDVA), and manifest refraction at the last follow-up visit. Results: 50% (n = 58) of eyes underwent FIIOL and 50% (n = 58) ICIOL implantation for aphakia (n = 44, 38%) and IOL dislocation (n = 72, 62%). No statistically significant differences in demographics, comorbidity, follow-up duration, postoperative complications, and surgical indications were found. The refractive prediction error (RPE) was 0.69 ± 0.94 diopter (D) in the FIIOL group and 0.21 ± 0.75 D in the ICIOL group (P = .03), indicating residual hyperopia after both techniques. RPE, mean absolute error, and median absolute error were higher in the FIIOL group (P = .003). ICIOL implantation was more successful in obtaining a RPE between −0.50 D and +0.50 D (52% of ICIOL, n = 30, and 31% of FIIOL, n = 18). Conclusions: Both techniques were effective in increasing preoperative CDVA with no statistical difference between them. Although complication rates did not significantly differ, the FIIOL group exhibited less predictable refractive outcomes. Adjusting the dioptric power of the 3-piece IOL, as performed in ciliary sulcus implantation, to prevent myopic shift, is not recommended.